Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
about
Therapy-related myeloid neoplasms: when genetics and environment collide.Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.CHIP, ICUS, CCUS and other four-letter words.Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.Chipping in on clonal hematopoiesis.Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions.Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia.Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management.Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine.Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias.Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential.Clonal evolution in leukemia.Clonality in context: hematopoietic clones in their marrow environment.Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestry.Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens.Age-related clonal hematopoiesis and monoclonal B-cell lymphocytosis/chronic lymphocytic leukemia: a new association?Therapy-related myeloid neoplasms: clinical perspectivesLudwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives
P2860
Q38611096-5FD4FCF5-0790-402E-9C3C-F9E6BE810CDAQ38627087-D3ABA97F-142A-4903-BDA3-7E1FD36B00EAQ38891536-FC40E506-03A0-4A17-88AA-1A0E021C2444Q39358533-B374815A-9437-40A9-AA74-AA520BDDDB4AQ40150370-24B71370-94A4-4FA9-93BC-A691C8B4B7E5Q45745039-8A772EB0-6806-4DF6-9C73-11B1F9DDF837Q47124670-6CD4BFF0-BE12-4549-9240-6FD265724613Q47128550-849D517B-7A46-40F7-A805-F044801622DAQ47158332-D6037217-E431-4D38-B0EC-DB44B99AC4D3Q47548041-07CF869F-CC1A-4F23-B0A9-856AE9B72290Q47655977-F2B9039D-1205-4866-881B-297E93841D00Q48191937-4C98E19E-ABD3-4C7A-A5BC-53D6C18DA1E6Q48228263-CB8C33B8-B1B0-4E77-A236-460906BDA20EQ49200018-226B2619-C55D-41AD-97F3-4014B8770D4CQ49557852-46F17165-E209-4096-9BF4-4DC04B5A630DQ50091222-D209591C-F4BE-4171-9868-C1CFC83379EFQ50209900-297517A5-CD01-459D-832B-B392E99F51D1Q52547022-979FD60C-2DDF-4A68-83B9-C826BC05D6A2Q52573507-84FC651D-6486-412B-8D64-B63D4BF91E1CQ55400468-885BC7E1-82AF-4232-B589-AFBCDDA5419BQ57074546-D2F32C31-26BA-4671-BDEB-B6113D00DC25Q57176232-8E6189C4-8A7A-4E61-A57B-1145DAA9B1BF
P2860
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preleukaemic clonal haemopoies ...... oplasms: a case-control study.
@en
type
label
Preleukaemic clonal haemopoies ...... oplasms: a case-control study.
@en
prefLabel
Preleukaemic clonal haemopoies ...... oplasms: a case-control study.
@en
P2093
P2860
P50
P1433
P1476
Preleukaemic clonal haemopoies ...... oplasms: a case-control study.
@en
P2093
Carlos Bueso-Ramos
Courtney D DiNardo
Curtis Gumbs
Denaha Doss
Erika Thompson
Felipe Samaniego
Jianhua Zhang
Kanhav Khanna
Keyur Patel
P2860
P304
P356
10.1016/S1470-2045(16)30626-X
P577
2016-12-02T00:00:00Z